Home and Clinical Laboratory Improvement Amendments-Waived Testing for Infectious Diseases-How Do These Fit in the Testing Landscape?
Copyright © 2023 Elsevier Inc. All rights reserved..
Though testing for infectious diseases has long been performed in traditional clincial laboratory settings, more widespread availability of waived testing is expanding accessibility of patients to rapid test results. This is being further expanded to home testing. Nevertheless, with this greater democratization and availability of clinical testing there are important limitations that need to be balanced. In this article, we review the current test landscape for infectious diseases waived testing and opportunities for assuring optimal quality testing.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
|---|---|
| Enthalten in: |
Clinics in laboratory medicine - 44(2024), 1 vom: 29. März, Seite 13-21 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lu, Jacky [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antigen-based CLIA-waived testing |
|---|
| Anmerkungen: |
Date Completed 29.01.2024 Date Revised 10.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.cll.2023.10.005 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367712083 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367712083 | ||
| 003 | DE-627 | ||
| 005 | 20240411232255.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240128s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.cll.2023.10.005 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1372.xml |
| 035 | |a (DE-627)NLM367712083 | ||
| 035 | |a (NLM)38280794 | ||
| 035 | |a (PII)S0272-2712(23)00110-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lu, Jacky |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Home and Clinical Laboratory Improvement Amendments-Waived Testing for Infectious Diseases-How Do These Fit in the Testing Landscape? |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 29.01.2024 | ||
| 500 | |a Date Revised 10.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 Elsevier Inc. All rights reserved. | ||
| 520 | |a Though testing for infectious diseases has long been performed in traditional clincial laboratory settings, more widespread availability of waived testing is expanding accessibility of patients to rapid test results. This is being further expanded to home testing. Nevertheless, with this greater democratization and availability of clinical testing there are important limitations that need to be balanced. In this article, we review the current test landscape for infectious diseases waived testing and opportunities for assuring optimal quality testing | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Antigen-based CLIA-waived testing | |
| 650 | 4 | |a Clinical Laboratory Improvement Amendments | |
| 650 | 4 | |a Emergency use authorization | |
| 650 | 4 | |a Home or over-the-counter testing | |
| 700 | 1 | |a Butler-Wu, Susan M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinics in laboratory medicine |d 1984 |g 44(2024), 1 vom: 29. März, Seite 13-21 |w (DE-627)NLM012672556 |x 1557-9832 |7 nnns |
| 773 | 1 | 8 | |g volume:44 |g year:2024 |g number:1 |g day:29 |g month:03 |g pages:13-21 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cll.2023.10.005 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 44 |j 2024 |e 1 |b 29 |c 03 |h 13-21 | ||